Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Proteomics International Laboratories (ASX: PIQ) is making great headway! CEO interview
June 5, 2025
PIQ, Proteomics International Laboratories
Proteomics International Laboratories (ASX: PIQ)
We spoke with Dr. Richard Lipscombe, CEO of Proteomics International Laboratories (ASX: PIQ), about the strong commercial prospects of his PromarkerD diagnostic for kidney disease now that the product is available for clinical use.
We also spoke about the valuable pipeline that it’s building, with diagnostics for endometriosis and esophageal cancer. PIQ’ platform, allowing the easy characterisation of proteins, has considerable upside that is only now being tapped.
PIQ is a research client of Pitt Street Research. Check out all research on PIQ HERE!
Looking for the Best ASX Life Sciences stocks to invest in right now?
